KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $1.4 billion.

  • Medtronic's Profit After Tax rose 805.95% to $1.4 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $4.8 billion, marking a year-over-year increase of 1082.33%. This contributed to the annual value of $4.7 billion for FY2025, which is 2661.27% up from last year.
  • As of Q4 2025, Medtronic's Profit After Tax stood at $1.4 billion, which was up 805.95% from $1.0 billion recorded in Q3 2025.
  • Medtronic's 5-year Profit After Tax high stood at $1.5 billion for Q2 2022, and its period low was $435.0 million during Q4 2022.
  • For the 5-year period, Medtronic's Profit After Tax averaged around $1.1 billion, with its median value being $1.2 billion (2023).
  • Its Profit After Tax has fluctuated over the past 5 years, first surged by 16659.92% in 2021, then plummeted by 6697.04% in 2022.
  • Over the past 5 years, Medtronic's Profit After Tax (Quarter) stood at $1.3 billion in 2021, then crashed by 66.97% to $435.0 million in 2022, then surged by 109.43% to $911.0 million in 2023, then soared by 40.29% to $1.3 billion in 2024, then increased by 8.06% to $1.4 billion in 2025.
  • Its Profit After Tax was $1.4 billion in Q4 2025, compared to $1.0 billion in Q3 2025 and $1.1 billion in Q2 2025.